Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Health insurers, including Cigna, Humana and Elevance Health, are tucking changes to DEI strategies and business risks into ...

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

“They continue to report, year-over-year ... it will continue using data-driven insights to simplify health care. Yet Elevance is subject to pressures far beyond Wall Street.

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” fourth quarter 2024 investor ...

See if the 14 Elevance Health analysts we track are forecasting continued growth with our free report on analyst estimates for the company. If you are a dividend investor, you might also want to ...